Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Influenza Hemagglutinin (HA) Peptide: Advanced Tag for Pr...

    2026-02-08

    Influenza Hemagglutinin (HA) Peptide: Advanced Tag for Protein Purification and Detection

    Principle and Setup: The Power of the HA Tag

    The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) has become a cornerstone in molecular biology and protein biochemistry, serving as a versatile epitope tag for protein detection, purification, and elution. This synthetic nine-amino acid peptide, derived from the human influenza hemagglutinin epitope, is especially valued for its ability to competitively bind to Anti-HA antibodies, enabling highly specific detection and efficient recovery of HA-tagged fusion proteins in diverse workflows.

    Supplied by APExBIO at >98% purity (validated by HPLC and mass spectrometry), and exhibiting exceptional solubility—≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water—the peptide demonstrates remarkable buffer compatibility. Its robust performance streamlines applications from protein-protein interaction studies and immunoprecipitation with Anti-HA antibody to advanced exosome research and mechanistic dissection of cellular pathways.

    Why Use the HA Tag Peptide?

    • High specificity and affinity for Anti-HA antibodies, minimizing background.
    • Minimal impact on protein folding or function due to its small size.
    • Facilitates elution via competitive binding, enabling gentle recovery of fusion proteins.
    • Well-characterized DNA and nucleotide sequences for straightforward cloning (ha tag sequence, ha tag dna sequence, ha tag nucleotide sequence).

    Stepwise Workflow Enhancements: From Transfection to Purity

    1. Cloning and Expression

    Begin by fusing the ha tag to the N- or C-terminus of your protein of interest, using established ha tag dna sequence or ha tag nucleotide sequence motifs for insertion into expression vectors. Ensure sequence verification by Sanger sequencing.

    2. Cell Culture and Transfection

    Express the ha fusion protein in a suitable cell line. Optimize transfection conditions (e.g., DNA:transfection reagent ratios) to maximize expression while minimizing cytotoxicity.

    3. Lysis and Preparation

    • Lysate preparation should use detergents compatible with downstream immunoprecipitation with Anti-HA antibody (e.g., NP-40 or Triton X-100-based buffers).
    • Protease inhibitors are essential for preserving target protein integrity.

    4. Immunoprecipitation and Protein Capture

    Incubate lysates with Anti-HA magnetic beads or agarose-conjugated Anti-HA antibodies. The high-affinity interaction between the HA tag and antibody facilitates selective binding, even from complex lysates.

    5. Elution Using Influenza Hemagglutinin (HA) Peptide

    To recover your target protein, add the Influenza Hemagglutinin (HA) Peptide. The synthetic peptide outcompetes the HA-tagged protein for antibody binding sites, enabling gentle elution without harsh denaturants. This is especially valuable for preserving protein-protein interactions and native conformations—crucial for downstream functional assays.

    6. Analysis and Validation

    • Analyze eluates by SDS-PAGE and immunoblotting with Anti-HA or protein-specific antibodies.
    • For interaction studies, probe for co-precipitated partners.
    • Quantify recovery efficiency; typical yields with HA peptide elution are >90% for well-expressed constructs (see Applied Workflows with Influenza Hemagglutinin (HA) Peptide).

    Advanced Applications and Comparative Advantages

    Exosome Biology and ESCRT-Independent Pathways

    Recent advances have leveraged the HA tag to dissect mechanisms of exosome biogenesis, especially in studies where conventional sorting pathways are disrupted. For example, the landmark research by Wei et al. (RAB31 marks and controls an ESCRT-independent exosome pathway) employed HA-tagged constructs to track and isolate key regulatory proteins, uncovering how RAB31 and flotillin orchestrate ESCRT-independent intraluminal vesicle (ILV) formation. The gentle elution enabled by the HA peptide preserved labile interactions, allowing high-fidelity mapping of protein complexes involved in exosome secretion and cargo sorting.

    Protein-Protein Interaction Mapping

    The molecular biology peptide tag format of the HA peptide is optimal for co-immunoprecipitation and interaction studies. Its small size and high specificity reduce steric hindrance and non-specific binding, enhancing the resolution of interaction networks. In translational research, as highlighted by Translational Power Plays: Elevating Mechanistic Discovery, the HA tag has enabled precision mapping of ubiquitin pathway regulators in cancer models.

    Complementary Resources and Comparative Insights

    Troubleshooting and Optimization: Achieving Reproducibility

    Common Challenges and Solutions

    • Low Recovery of HA Fusion Proteins: Insufficient peptide concentration or incomplete competitive binding can reduce elution efficiency. Titrate the HA peptide from 0.1–1 mg/mL; optimal concentrations often reside at 0.5 mg/mL for high-capacity beads.
    • Non-Specific Binding: Ensure thorough pre-clearing of lysates and incorporate stringent washes (e.g., 0.5 M NaCl or 0.1% SDS) without compromising target protein stability.
    • Protein Degradation: Minimize freeze-thaw cycles and always include a protease inhibitor cocktail. Prepare fresh peptide solutions immediately before use and avoid long-term storage, as per APExBIO guidelines.
    • Solubility Issues: Dissolve the HA peptide in DMSO, ethanol, or water according to downstream buffer compatibility; concentrations up to 100 mg/mL are feasible, supporting even high-throughput workflows.
    • Cross-reactivity in Detection: Use monoclonal Anti-HA antibodies for immunoblotting to minimize cross-reactivity, and validate using alternative tags or detection strategies.

    Optimization Strategies

    • For protein-protein interaction studies, minimize detergent concentrations to preserve labile complexes, while leveraging the gentle elution afforded by the HA tag.
    • When working with exosome preparations, integrate differential centrifugation and size-exclusion chromatography to minimize contaminant co-isolation, as recommended in Influenza Hemagglutinin (HA) Peptide: Precision Tools for Protein Interaction Studies.
    • Apply quantitative controls (spike-in standards or recombinant HA-tagged proteins) to benchmark recovery rates and ensure cross-experimental reproducibility.

    Future Outlook: Expanding Functional Horizons

    With the rapid evolution of proteomics, cell signaling, and exosome biology, the HA tag peptide is poised for even broader impact. Advances in single-cell proteomics and proximity labeling will increasingly rely on robust, high-affinity protein purification tags that enable gentle, high-yield recovery without compromising complex integrity. The unique combination of solubility, purity, and competitive binding efficiency offered by the Influenza Hemagglutinin (HA) Peptide from APExBIO positions it as a trusted solution for next-generation experimental designs.

    Furthermore, integration with CRISPR-based endogenous tagging strategies and multiplexed detection systems will further elevate the HA tag's utility in both basic and translational research. As exemplified by the referenced Cell Research study, the ability to dissect dynamic protein networks in ESCRT-independent exosome pathways is only the beginning—future innovations will harness the HA tag's molecular precision to unravel mechanisms underlying disease, immunity, and cellular communication.

    Conclusion

    The Influenza Hemagglutinin (HA) Peptide stands as a gold-standard epitope tag for molecular biology, enabling robust, reproducible protein purification, detection, and mechanistic discovery. Its high purity, solubility, and selectivity—backed by APExBIO's rigorous quality control—empower scientists to execute sophisticated workflows with confidence. Whether advancing exosome biology, mapping protein-protein interaction landscapes, or purifying labile complexes, the HA tag peptide remains an indispensable tool for the modern molecular laboratory.